Global markets and politics are colliding as power, technology, and capital flow come under renewed strain.In the United States, escalating federal threats overGlobal markets and politics are colliding as power, technology, and capital flow come under renewed strain.In the United States, escalating federal threats over

Evening digest: Trump’s troop threat, Ford–BYD talks, TSMC’s Q4 earnings

Global markets and politics are colliding as power, technology, and capital flow come under renewed strain.

In the United States, escalating federal threats over civil unrest raise constitutional stakes, while automakers confront hard realities about the pace of electrification.

In Asia, blockbuster semiconductor earnings underscore AI’s economic pull even as geopolitics loom large.

Meanwhile, a pivotal Indian tax ruling could redefine the rules for foreign investors navigating one of the world’s fastest-growing markets.

Trump threatens to deploy troops in Minnesota over ICE protests

US President Trump has threatened to invoke the Insurrection Act against Minnesota, escalating federal-state tensions over governance disputes.

The threat represents an extraordinary assertion of executive power, raising constitutional alarms among legal scholars and state officials.

Minnesota’s Democratic leadership has pushed back forcefully, labeling the move a dangerous overreach that undermines federalism principles.

Constitutional experts warn that such an invocation could trigger prolonged court battles and set a precedent for unprecedented executive intervention.

The standoff reflects deepening political polarization and power struggles between Washington and state governments.

Ford-BYD pivot towards hybrids

Ford’s negotiations with Chinese battery giant BYD signal Detroit’s strategic pivot toward hybrids as EV demand crumbles.

The automaker, which took a staggering $19.5 billion EV charge last month, is exploring importing BYD batteries for hybrid models produced outside the United States.

This partnership would tap BYD’s dominance, as the company controls roughly 55% of global EV battery production alongside CATL.

Ford’s hybrid sales surged 18% year-over-year in Q4 2025, hitting 55,000 units, underscoring market realities.

While negotiations remain preliminary with no guarantees, the deal reflects industry-wide recognition that battery-electric vehicles aren’t delivering profits.

BYD’s proven cost advantages and technology could give Ford competitive breathing room in the lucrative hybrid segment.

TSMC’s blockbuster Q4 earnings

Taiwan Semiconductor Manufacturing Company has posted record fourth-quarter profits, driven by insatiable artificial intelligence chip demand that’s reshaping the semiconductor industry.

TSMC’s market valuation has surged past NT$1 trillion, reflecting investor confidence in sustained AI-driven growth.

The chipmaker’s advanced manufacturing capacity remains the bottleneck for global AI development, with major tech companies competing fiercely for production slots.

Profit margins expanded significantly as AI customers accept premium pricing for cutting-edge nodes.

Geopolitical tensions around Taiwan add volatility to TSMC’s outlook, yet demand fundamentals remain robust.

Analysts project continued momentum through 2026, though supply constraints could eventually cap growth potential.

India’s tax court weighs in on Tiger Global-Walmart deal

An Indian court is set to rule on Tiger Global’s controversial 2018 Walmart transaction, potentially reshaping how the nation handles foreign investment taxation.

The case centers on whether Tiger Global’s exit from Flipkart through Walmart’s 2018 acquisition triggered taxable gains under Indian law.

The landmark decision could establish precedent for how New Delhi treats foreign venture capital exits and cross-border M&A transactions.

Tax authorities had previously challenged the deal’s valuation methodology.

A ruling favoring India’s tax position could expose other foreign investors to retroactive assessments.

The judgment carries implications beyond Tiger Global, affecting venture capital confidence in India’s investment ecosystem and regulatory predictability.

The post Evening digest: Trump’s troop threat, Ford–BYD talks, TSMC’s Q4 earnings appeared first on Invezz

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$5.331
$5.331$5.331
-1.87%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23